William Arsani 4
4 · Design Therapeutics, Inc. · Filed Aug 12, 2024
Insider Transaction Report
Form 4
William Arsani
Director
Transactions
- Sale
Common Stock
2024-08-09$4.25/sh−814,874$3,463,215→ 0 total(indirect: By Logos SPV I LP)
Holdings
- 1,217,627(indirect: By Logos Opportunities Fund II, L.P.)
Common Stock
- 3,000,000(indirect: By Logos Global Master Fund LP)
Common Stock
Footnotes (2)
- [F1]Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II") and Logos SPV 1 LP ("SPV 1"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. Logos Opportunities II GP LLC ("GP II") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F2]Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.